AUPR916301A0 - Pyrazolopyridine compound and pharmaceutical use thereof - Google Patents

Pyrazolopyridine compound and pharmaceutical use thereof

Info

Publication number
AUPR916301A0
AUPR916301A0 AUPR9163A AUPR916301A AUPR916301A0 AU PR916301 A0 AUPR916301 A0 AU PR916301A0 AU PR9163 A AUPR9163 A AU PR9163A AU PR916301 A AUPR916301 A AU PR916301A AU PR916301 A0 AUPR916301 A0 AU PR916301A0
Authority
AU
Australia
Prior art keywords
pharmaceutical use
pyrazolopyridine compound
pyrazolopyridine
compound
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR9163A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AUPR9163A priority Critical patent/AUPR916301A0/en
Publication of AUPR916301A0 publication Critical patent/AUPR916301A0/en
Priority to PCT/JP2002/012381 priority patent/WO2003045950A1/fr
Priority to AU2002347633A priority patent/AU2002347633A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AUPR9163A 2001-11-29 2001-11-29 Pyrazolopyridine compound and pharmaceutical use thereof Abandoned AUPR916301A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPR9163A AUPR916301A0 (en) 2001-11-29 2001-11-29 Pyrazolopyridine compound and pharmaceutical use thereof
PCT/JP2002/012381 WO2003045950A1 (fr) 2001-11-29 2002-11-27 Dérivés de pyrazolopyridine et leur utilisation pharmaceutique
AU2002347633A AU2002347633A1 (en) 2001-11-29 2002-11-27 Pyrazolopyridine derivtives and their pharmaceutical use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR9163A AUPR916301A0 (en) 2001-11-29 2001-11-29 Pyrazolopyridine compound and pharmaceutical use thereof

Publications (1)

Publication Number Publication Date
AUPR916301A0 true AUPR916301A0 (en) 2001-12-20

Family

ID=3832973

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR9163A Abandoned AUPR916301A0 (en) 2001-11-29 2001-11-29 Pyrazolopyridine compound and pharmaceutical use thereof

Country Status (2)

Country Link
AU (1) AUPR916301A0 (fr)
WO (1) WO2003045950A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
US7585875B2 (en) 2006-06-06 2009-09-08 Avigen, Inc. Substituted pyrazolo[1,5-a]pyridine compounds and their methods of use
US20110039343A1 (en) * 2008-02-01 2011-02-17 Brahms Aktiengesellschaft Method for the identification of patients in need of therapy having minor cognitive disorders and the treatment of such patients
CN102781930B (zh) 2009-12-18 2016-03-23 田边三菱制药株式会社 抗血小板药
US8871754B2 (en) 2012-11-19 2014-10-28 Irm Llc Compounds and compositions for the treatment of parasitic diseases
RS56720B1 (sr) 2012-11-19 2018-03-30 Novartis Ag Jedinjenja i kompozicije za lečenje parazitskih oboljenja

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901423D0 (en) * 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof

Also Published As

Publication number Publication date
WO2003045950A1 (fr) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2002349705A1 (en) Azole compound and medicinal use thereof
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
HUP0302857A3 (en) Pharmaceutical formulation
GB0118689D0 (en) Pharmaceutical formulation
AU2002257582A1 (en) Pharmaceutical formulation
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
PL366432A1 (en) Pharmaceutical formulation
AU2003281044A1 (en) Pyrrolopyridine derivative and use thereof
AU2002354410A1 (en) Triazole compound and medicinal use thereof
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2002251448A1 (en) Oral absorbed drugs
AU2002308889A1 (en) Novel heterocyclic compound and medicinal use thereof
AUPR916301A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPP672198A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPQ462299A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR606401A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2002347633A1 (en) Pyrazolopyridine derivtives and their pharmaceutical use
AUPS092602A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
GB0104749D0 (en) Pharmaceutical formulation
AU2002323963A1 (en) Beta-ketoamide compounds and medicinal use thereof